Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity

Journal of Clinical Microbiology

Volumn 35, Issue 8, 1997, Pages 1972-1977

  Jenum, Pål A ^a   Stray Pedersen, Babill ^b   Gundersen, Anne Gerd ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 0030743561     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.8.1972-1977.1997     Document Type: Article

References (25)

1. Altman, D. G. 1991. Practical statistics for medical research. Chapman & Hall, London, United Kingdom.
2. Beverly, J. K. A., and C. P. Beattie. 1958. Glandular toxoplasmosis. A survey of 30 cases. Lancet ii:379-384.
3. Daffos, F., F. Forestier, M. Capella-Pavlovsky, P. Thulliez, C. Aufrant, D. Valenti, and W. L. Cox. 1988. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N. Engl. J. Med. 318:271-275.
4. Desmonts, G., F. Forestier, P. Thulliez, F. Daffos, M. Capella-Pavlovsky, and M. Chartier. 1985. Prenatal diagnosis of congenital toxoplasmosis. Lancet i:500-504.
5. Feldman, H. A., and G. A. Lamb. 1966. A micromodification of the toxoplasma dye test. J. Parasitol. 52:415.
6. Francis, J. M., and D. H. M. Joynson. 1993. Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorhent agglutination assay. Eur. J. Clin. Microbiol. Infect. Dis. 12:556-559.
7. Hedman, K., M. Lappalainen, I. Seppälä, and O. Mäkelä. 1989. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159:736-740.
8. Ho-Yen, D. O. Clinical features, p. 56-78. In D. O. Ho-Yen, and A. W. L. Joss (ed.), Human toxoplasmosis. Oxford Medical Publications, Oxford, United Kingdom.
9. Hohlfeld, P., F. Daffos, P. Thulliez, C. Aufrant, J. Couvreur, J. MacAleese, D. Descombey, and F. Forestier. 1989. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J. Pediatr. 115:765-769.
10. Holliman, R. E., R. Raymond, N. Renton, and J. D. Johnson. 1994. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol. Infect. 112:399-408.
11. Joss, A. W. L. Diagnosis, p. 79-118. In D. O. Ho-Yen and A. W. L. Joss (ed.), Human toxoplasmosis. Oxford Medical Publications, Oxford, United Kingdom.
12. Joynson, D. H. M., R. A. Payne, and B. K. Rawal. 1990. Potential role of IgG avidity for diagnosing toxoplasmosis. J. Clin. Pathol. 43:1032-1033.
13. Lappalainen, M., P. Koskela, M. Koskiniemi, P. Ämmälä, V. Hiilesmaa, K. Teramo, K. O. Raivio, J. S. Remington, and K. Hedman. 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 167:691-697.
14. Lebech, M., D. H. M. Joynson, H. M. Seitz, P. Thulliez, R. E. Gilbert, G. N. Dutton, B. Øvlisen, and E. Petersen. 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur. J. Clin. Microbiol. Infect. Dis. 15:799-805.
15. Lebech, M., and E. Petersen. 1992. Neonatal screening for congenital toxoplasmosis in Denmark: presentation of the design of a prospective study. Scand. J. Infect. Dis. Suppl. 84:70-74.
16. Lecolier, B., and B. Pucheu. 1993. Interét de l'etude de l'avidité des IgG pour le diagnostic de la toxpplasmose. Pathol. Biol. 41:155-158.
17. McAuley, J., K. M. Boyer, D. Patel, M. Mets, C. Swisher, N. Roizen, C. Wolters, L. Stein, W. Sehey, J. Remington, P. Meier, D. Johnson, P. Heydeman, E. Holfels, S. Withers, D. Mack, C. Brown, D. Patton, and R. McLeod. 1994. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin. Infect. Dis. 18:38-72.
18. Naessens, A., W. Heuninckx, W. Foulon, and S. Lauwers. 1993. Evaluation of seven commercially available enzyme immunoassays for immunoglobulin G and M antibody detection of Toxoplasma gondii. Immunol. Infect. Dis. 3:258-262.
19. Remington, J. S., R. McLeod, and C. Desmonts. 1995. Toxoplasmosis, p. 140-267. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infant. 4th ed. The W. B. Saunders Company, Philadelphia, Pa.
20. Roitt, I. M. 1988. Essential immunology, 6th ed., p. 60-63. Blackwell Scientific Publications, Oxford, United Kingdom.
21. Sabin, A. B., and H. A. Feldman. 1948. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 108:660-663.
22. Sensini, A., S. Pascoli, D. Marchetti, R. Castronari, M. Marangi, G. Sbaraglia, C. Cimmino, A. Facero, M. Castelletto, and A. Mottola. 1996. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin. Microbiol. Infect. 2:25-29.
23. Stray-Pedersen, B. 1993. Toxoplasmosis in pregnancy. Clin. Obstet. Gynecol. 7:107-137.
24. Stray-Pedersen, B., and P. Jenum. 1992. Current status of toxoplasmosis in pregnancy in Norway. Scand. J. Infect. Dis. Suppl. 84:80-83.
25. Wong, S. Y., and J. S. Remington. 1994. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 18:853-862.